BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14986595)

  • 1. Assessment of the combined effect of plasma exchange and plasma perfusion on patients with severe hepatitis awaiting orthotopic liver transplantation.
    Wang YJ; He NH; Wang ZW; Niu RZ; Liu J; Wen HW; Li JJ; Li MD; Wang YM
    Int J Artif Organs; 2004 Jan; 27(1):40-4. PubMed ID: 14986595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthotopic liver transplantation in critically ill cirrhotic patients with multi-organ failure: a single-center experience.
    Umgelter A; Lange K; Kornberg A; Büchler P; Friess H; Schmid RM
    Transplant Proc; 2011 Dec; 43(10):3762-8. PubMed ID: 22172843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation.
    Annicchiarico BE; Avolio AW; Siciliano M; Passalacqua S; Caracciolo G; Gasbarrini A; Agnes S; Castagneto M
    Transplant Proc; 2008; 40(6):1929-31. PubMed ID: 18675092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up.
    Donati G; La Manna G; Cianciolo G; Grandinetti V; Carretta E; Cappuccilli M; Panicali L; Iorio M; Piscaglia F; Bolondi L; Colì L; Stefoni S
    Artif Organs; 2014 Feb; 38(2):125-34. PubMed ID: 23834711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation.
    Andreone P; Biselli M; Gramenzi A; Cursaro C; Morelli MC; Sama C; Lorenzini S; Spinucci G; Porzio F; Felline F; Di Giammarino L; Bernardi M
    Transplantation; 2002 Oct; 74(8):1119-24. PubMed ID: 12438957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of liver transplantation in HCV/HIV coinfected haemophilia patients. A single centre study of 10 patients.
    Goldmann G; Zeitler H; Marquardt N; Horneff S; Balta Z; Strassburg CP; Oldenburg J
    Hamostaseologie; 2015; 35(2):175-80. PubMed ID: 25374048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation.
    Annicchiarico BE; Siciliano M; Avolio AW; Caracciolo G; Gasbarrini A; Agnes S; Castagneto M
    Transplant Proc; 2008; 40(6):1918-20. PubMed ID: 18675089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined twice-daily plasma exchange and continuous veno-venous hemodiafiltration for bridging severe acute liver failure.
    Biancofiore G; Bindi LM; Urbani L; Catalano G; Mazzoni A; Scatena F; Mosca F; Filipponi F
    Transplant Proc; 2003 Dec; 35(8):3011-4. PubMed ID: 14697964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver support in fulminant liver failure after hemorrhagic shock.
    Faybik P; Hetz H; Krenn CG; Baker A; Germann P; Berlakovich G; Steininger R; Steltzer H
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):595-8. PubMed ID: 14531174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined orthotopic heart and liver transplantation: the need for exception status listing.
    Porrett PM; Desai SS; Timmins KJ; Twomey CR; Sonnad SS; Olthoff KM
    Liver Transpl; 2004 Dec; 10(12):1539-44. PubMed ID: 15558654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of hepatitis B relapse after liver transplantation.
    Zhu X; Lu M; Wang G; Cai C; Yang Y; He X; Chen G; Huang J
    Chin Med J (Engl); 2001 Jan; 114(1):73-5. PubMed ID: 11779441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
    Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
    Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure.
    Novelli G; Rossi M; Pretagostini R; Poli L; Novelli L; Berloco P; Ferretti G; Iappelli M; Cortesini R
    Liver; 2002; 22 Suppl 2():43-7. PubMed ID: 12220303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with a porcine hepatocyte-based liver support system.
    Chen SC; Hewitt WR; Watanabe FD; Eguchi S; Kahaku E; Middleton Y; Rozga J; Demetriou AA
    Int J Artif Organs; 1996 Nov; 19(11):664-9. PubMed ID: 8970834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
    Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intensive PEX in a patient with fulminant hepatic failure due to Wilson's disease (WD) in preparation for orthotopic liver transplantation (OLT).
    Valbonesi M; Valente U; Andorno E; Ruzzenenti MR; Carlier P
    Int J Artif Organs; 2003 Oct; 26(10):965-6. PubMed ID: 14636015
    [No Abstract]   [Full Text] [Related]  

  • 20.  High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation.
    Shah JA; Patel MS; Kratz JR; Markmann JF; Vagefi PA
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):888-894. PubMed ID: 27740522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.